feed,title,long_url,short_url
BioRxiv,Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains,https://biorxiv.org/cgi/content/short/2022.03.17.484787v1?rss=1,https://bit.ly/37BYrop
BioRxiv,SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties,https://biorxiv.org/cgi/content/short/2022.03.18.484873v1?rss=1,https://bit.ly/3udwivo
BioRxiv,Prime-boost vaccinations with two serologically distinct chimpanzee adenovirus vectors expressing SARS-CoV-2 spike or nucleocapsid tested in a hamster COVID-19 model,https://biorxiv.org/cgi/content/short/2022.03.17.484786v1?rss=1,https://bit.ly/3qhgN4F
